Mucosal immunity and vaccines against simian immunodeficiency virus and human immunodeficiency virus

Mucosal Immunology, Two-Volume Set

Volumn , Issue , 2005, Pages 937-957

  McElrath, M Juliana ^a   Miller, Christopher J ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882870394     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012491543-5/50056-5     Document Type: Chapter

References (208)

1. Abel K., Compton L., Rourke T., Montefiori D., Lu D., Rothaeusler K., Fritts L., Bost K., Miller C.J. Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses. J. Virol. 2003, 77:3099-3118.
2. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., Berger E.A. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996, 272:1955-1958.
3. Almond N., Rose J., Sangster R., Silvera P., Stebbings R., Walker B., Stott E.J. Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum. J. Gen. Virol. 1997, 78:1919-1922. (Pt 8).
4. Amara R.R., Villinger F., Altman J.D., Lydy S.L., O'Neil S.P., Staprans S.I., Montefiori D.C., Xu Y., Herndon J.G., Wyatt L.S., Candido M.A., Kozyr N.L., Earl P.L., Smith J.M., Ma H.L., Grimm B.D., Hulsey M.L., Miller J., McClure H.M., McNicholl J.M., Moss B., Robinson H.L. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 2001, 292:69-74.
5. Archibald D.W., Witt D.J., Craven D.E., Vogt M.W., Hirsch M.S., Essex M. Antibodies to human immunodeficiency virus in cervical secretions from women at risk for AIDS. J. Infect. Dis. 1987, 156:240-241.
6. Artenstein A.W., VanCott T.C., Sitz K.V., Robb M.L., Wagner K.F., Veit S.C., Rogers A.F., Garner R.P., Byron J.W., Burnett P.R., Birx D.L. Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information. J. Infect. Dis. 1997, 175:265-271.
7. Bagarazzi M.L., Boyer J.D., Javadian M.A., Chattergoon M.A., Shah A.R., Cohen A.D., Bennett M.K., Ciccarelli R.B., Ugen K.E., Weiner D.B. Systemic and mucosal immunity is elicited after both intramuscular and intravaginal delivery of human immunodeficiency virus type 1 DNA plasmid vaccines to pregnant chimpanzees. J. Infect. Dis. 1999, 180:1351-1355.
8. Baig J., Levy D.B., McKay P.F., Schmitz J.E., Santra S., Subbramanian R.A., Kuroda M.J., Lifton M.A., Gorgone D.A., Wyatt L.S., Moss B., Huang Y., Chakrabarti B.K., Xu L., Kong W.P., Yang Z.Y., Mascola J.R., Nabel G.J., Carville A., Lackner A.A., Veazey R.S., Letvin N.L. Elicitation of simian immunodeficiency virus-specific cytotoxic T lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccination. J. Virol. 2002, 76:11484-11490.
9. Barouch D.H., Santra S., Schmitz J.E., Kuroda M.J., Fu T.M., Wagner W., Bilska M., Craiu A., Zheng X.X., Krivulka G.R., Beaudry K., Lifton M.A., Nickerson C.E., Trigona W.L., Punt K., Freed D.C., Guan L., Dubey S., Casimiro D., Simon A., Davies M.E., Chastain M., Strom T.B., Gelman R.S., Montefiori D.C., Lewis M.G., Emini E.A., Shiver J.W., Letvin N.L. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 2000, 290:486-492.
10. Bebenek K., Abbotts J., Roberts J.D., Wilson S.H., Kunkel T.A. Specificity and mechanism of error-prone replication by human immunodeficiency virus-1 reverse transcriptase. J. Biol. Chem. 1989, 264:16948-16956.
11. Belec L., Bouquety J.C., Georges A.J., Siopathis M.R., Martin P.M. Antibodies to human immunodeficiency virus in the breast milk of healthy, seropositive women. Pediatrics 1990, 85:1022-1026.
12. Belec L., Dupre T., Prazuck T., Tevi-Benissan C., Kanga J.M., Pathey O., Lu X.S., Pillot J. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection. J. Infect. Dis. 1995, 172:691-697.
13. Belec L., Georges A.J., Steenman G., Martin P.M. Antibodies to human immunodeficiency virus in vaginal secretions of heterosexual women. J. Infect. Dis. 1989, 160:385-391.
14. Belec L., Tevi-Benissan C., Dupre T., Mohamed A.S., Prazuck T., Gilquin J., Kanga J.M., Pillot J. Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection. J. Clin. Immunol. 1996, 16:12-20.
15. Belshe R.B., Stevens C., Gorse G.J., Buchbinder S., Weinhold K., Sheppard H., Stablein D., Self S., McNamara J., Frey S., Flores J., Excler J.L., Klein M., Habib R.E., Duliege A.M., Harro C., Corey L., Keefer M., Mulligan M., Wright P., Celum C., Judson F., Mayer K., McKirnan D., Marmor M., Woody G. Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp 120: a phase 2 study in higher-and lower-risk volunteers. J. Infect. Dis. 2001, 183:1343-1352.
16. Bergquist C., Johansson E.L., Lagergard T., Holmgren J., Rudin A. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect. Immun. 1997, 65:2676-2684.
17. Bhoopat L., Eiangleng L., Rugpao S., Frankel S.S., Weissman D., Lekawanvijit S., Petchjom S., Thorner P., Bhoopat T. In vivo identification of Langerhans and related dendritic cells infected with HIV-1 subtype E in vaginal mucosa of asymptomatic patients. Mod. Pathol. 2001, 14:1263-1269.
18. Bjercke S., Scott H., Braathen L.R., Thorsby E. HLA-DR-expressing Langerhans-like cells in vaginal and cervical epithelium. Acta Obstet. Gynecol. Scand. 1983, 62:585-589.
19. Blauvelt A., Asada H., Saville M.W., Klaus-Kovuton V., Altman D.J., Yarchoan R., Katz S.I. Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways. J. Clin. Invest. 1997, 100:2043-2053.
20. Borrow P., Lewicki H., Hahn B.H., Shaw G.M., Oldstone M.B. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 1994, 68:6103-6110.
21. Buchacz K., Parekh B.S., Padian N.S., van der Straten A., Phillips S., Jonte J., Holmberg S.D. HIV-specific IgG in cervicovaginal secretions of exposed HIV-uninfected female sexual partners of HIV-infected men. AIDS Res. Hum. Retroviruses 2001, 17:1689-1693.
22. Caley I.J., Betts M.R., Davis N.L., Swanstrom R., Frelinger J.A., Johnston R.E. Venezuelan equine encephalitis virus vectors expressing HIV-1 proteins: vector design strategies for improved vaccine efficacy. Vaccine 1999, 17(23-24):3124-3135.
23. Chou L.L., Epstein J., Cassol S.A., West D.M., He W., Firth J.D. Oral mucosal Langerhans' cells as target, effector and vector in HIV infection. J. Oral Pathol. Med. 2000, 29:394-402.
24. Ciurea A., Klenerman P., Hunziker L., Horvath E., Odermatt B., Ochsenbein A.F., Hengartner H., Zinkernagel R.M. Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice. Proc. Natl. Acad. Sci. USA 1999, 96:11964-11969.
25. Cohen C.R., Plummer F.A., Mugo N., Maclean I., Shen C., Bukusi E.A., Irungu E., Sinei S., Bwayo J., Brunham R.C. Increased interleukin-10 in the endocervical secretions of women with non-ulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission?. AIDS 1999, 13:327-332.
26. Collins K.B., Patterson B.K., Naus G.J., Landers D.V., Gupta P. Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract. Nat. Med. 2000, 6:475-479.
27. Cooney E.L., McElrath M.J., Corey L., Hu S.L., Collier A.C., Arditti D., Hoffman M., Coombs R.W., Smith G.E., Greenberg P.D. Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein. Proc. Natl. Acad. Sci. USA 1993, 90:1882-1886.
28. Corey L., McElrath M.J., Weinhold K., Matthews T., Stablein D., Graham B., Keefer M., Schwartz D., Gorse G. Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group. J. Infect. Dis. 1998, 177:301-309.
29. Couedel-Courteille A., Butor C., Juillard V., Guillet J.G., Venet A. Dissemination of SIV after rectal infection preferentially involves paracolic germinal centers. Virology 1999, 260:277-294.
30. Crowley-Nowick P.A., Bell M., Edwards R.P., McCallister D., Gore H., Kanbour-Shakir A., Mestecky J., Partridge E.E. Normal uterine cervix: characterization of isolated lymphocyte phenotypes and immunoglobulin secretion. Am. J. Reprod. Immunol. 1995, 34(4):241-247.
31. Daniel M.D., Kirchhoff F., Czajak S.C., Sehgal P.K., Desrosiers R.C. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 1992, 258:1938-1941.
32. Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., Goedert J.J., Buchbinder S.P., Vittinghoff E., Gomperts E., Donfield S., Vlahov D., Kaslow R., Saah A., Rinaldo C., Detels R., O'Brien S.J. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco Cohort, ALIVE Study. Science 1996, 273:1856-1862.
33. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., Davis C.B., Peiper S.C., Schall T.J., Littman D.R., Landau N.R. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996, 381:661-666.
34. Desrosiers R.C., Letvin N.L. Animal models for acquired immunodeficiency syndrome. Rev. Infect. Dis. 1987, 9:438-446.
35. Dezzutti C.S., Guenthner P.C., Cummins J.E., Cabrera T., Marshall J.H., Dillberger A., Lal R.B. Cervical and prostate primary epithelial cells are not productively infected but sequester human immunodeficiency virus type 1. J. Infect. Dis. 2001, 183:1204-1213.
36. Di Stefano M., Favia A., Monno L., Lopalco P., Caputi O., Scardigno A.C., Pastore G., Fiore J.R., Angarano G. Intracellular and cell-free (infectious) HIV-1 in rectal mucosa. J. Med. Virol. 2001, 65:637-643.
37. Dorrell L., Hessell A.J., Wang M., Whittle H., Sabally S., Rowland-Jones S., Burton D.R., Parren P.W. Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia. AIDS 2000, 14:1117-1122.
38. Douek D.C., Picker L.J., Koup R.A. T cell dynamics in HIV-1 infection. Annu. Rev. Immunol. 2003, 21:265-304.
39. Dragic T., Litwin V., Allaway G.P., Martin S.R., Huang Y., Nagashima K.A., Cayanan C., Maddon P.J., Koup R.A., Moore J.P., Paxton W.A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381:667-673.
40. Duprat C., Mohammed Z., Datta P., Stackiw W., Ndinya-Achola J.O., Kreiss J.K., Holmes K.K., Plummer F.A., Embree J.E. Human immunodeficiency virus type 1 IgA antibody in breast milk and serum. Pediatr. Infect. Dis. J. 1994, 13:603-608.
41. Edwards J.N., Morris H.B. Langerhans' cells and lymphocyte subsets in the female genital tract. Br. J. Obstet. Gynaecol. 1985, 92:974-982.
42. Embree J.E., Njenga S., Datta P., Nagelkerke N.J., Ndinya-Achola J.O., Mohammed Z., Ramdahin S., Bwayo J.J., Plummer F.A. Risk factors for postnatal mother-child transmission of HIV-1. AIDS 2000, 14:2535-2541.
43. Eriksson K., Kilander A., Hagberg L., Norkrans G., Holmgren J., Czerkinsky C. Virus-specific antibody production and polyclonal B-cell activation in the intestinal mucosa of HIV-infected individuals. AIDS 1995, 9:695-700.
44. Eriksson K., Quiding-Jarbrink M., Osek J., Moller A., Bjork S., Holmgren J., Czerkinsky C. Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination. Infect. Immun. 1998, 66(12):5889-5896.
45. Evans D.T., Chen L.M., Gillis J., Lin K.C., Harty B., Mazzara G.P., Donis R.O., Mansfield K.G., Lifson J.D., Desrosiers R.C., Galan J.E., Johnson R.P. Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system. J. Virol. 2003, 77:2400-2409.
46. Evans D.T., Desrosiers R.C. Immune evasion strategies of the primate lentiviruses. Immunol. Rev. 2001, 183:141-158.
47. + cytotoxic T lymphocyte responses in seronegative volunteers. J. Infect. Dis. 1999, 180:290-298.
48. Farquhar C., VanCott T.C., Mbori-Ngacha D.A., Horani L., Bosire R.K., Kreiss J.K., Richardson B.A., John-Stewart G.C. Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk. J. Infect. Dis. 2002, 186:1173-1176.
49. Faruque S., Edlin B.R., McCoy C.B., Word C.O., Larsen S.A., Schmid D.S., Von Bargen J.C., Serrano Y. Crack cocaine smoking and oral sores in three inner-city neighborhoods. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1996, 13:87-92.
50. Fawcett D.W. Bloom and Fawcett's Textbook of Histology 1986, WB Saunders, Philadelphia.
51. Feinberg M.B., Moore J.P. AIDS vaccine models: challenging challenge viruses. Nat. Med. 2002, 8:207-210.
52. Ferrantelli F., Ruprecht R.M. Neutralizing antibodies against HIV: back in the major leagues?. Curr. Opin. Immunol. 2002, 14(4):495-502.
53. Fotopoulos G., Harari A., Michetti P., Trono D., Pantaleo G., Kraehenbuhl J.P. Transepithelial transport of HIV-1 by M cells is receptor-mediated. Proc. Natl. Acad. Sci. USA 2002, 99:9410-9414.
54. Francis D.P., Heyward W.L., Popovic V., Orozco-Cronin P., Orelind K., Gee C., Hirsch A., Ippolito T., Luck A., Longhi M., Gulati V., Winslow N., Gurwith M., Sinangil F., Berman P.W. Candidate HIV/AIDS vaccines: lessons learned from the World's first phase III efficacy trials. AIDS 2003, 17:147-156.
55. Gaillard P., Verhofstede C., Mwanyumba F., Claeys P., Chohan V., Mandaliya K., Bwayo J., Plum J., Temmerman M. Exposure to HIV-1 during delivery and mother-to-child transmission. AIDS 2000, 14(15):2341-2348.
56. Geijtenbeek T.B., Kwon D.S., Torensma R., van Vliet S.J., van Duijnhoven G.C., Middel J., Cornelissen I.L., Nottet H.S., KewalRamani V.N., Littman D.R., Figdor C.G., van Kooyk Y. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100:587-597.
57. Goedert J.J., Duliege A.M., Amos C.I., Felton S., Biggar R.J. High risk of HIV-1 infection for first-born twins. The International Registry of HIV-exposed Twins. Lancet 1991, 338:1471-1475.
58. Gray R.H., Wawer M.J., Brookmeyer R., Sewankambo N.K., Serwadda D., Wabwire-Mangen F., Lutalo T., Li X., vanCott T., Quinn T.C. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001, 357:1149-1153.
59. Greenhead P., Hayes P., Watts P.S., Laing K.G., Griffin G.E., Shattock R.J. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J. Virol. 2000, 74:5577-5586.
60. Greenier J.L., Miller C.J., Lu D., Dailey P.J., Lu F.X., Kunstman K.J., Wolinsky S.M., Marthas M.L. Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques. J. Virol. 2001, 75(8):3753-3765.
61. Grosskurth H., Mosha F., Todd J., Mwijarubi E., Klokke A., Senkoro K., Mayaud P., Changalucha J., Nicoll A., ka-Gina G. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995, 346:530-536.
62. Grossman C.J. Regulation of the immune system by sex steroids. Endocr. Rev. 1984, 5:435-455.
63. Gupta K., Hudgens M., Corey L., McElrath M.J., Weinhold K., Montefiori D.C., Gorse G.J., Frey S.E., Keefer M.C., Evans T.G., Dolin R., Schwartz D.H., Harro C., Graham B., Spearman P.W., Mulligan M., Goepfert P. Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp 120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A. J. Acquir. Immune Defic. Syndr. 2002, 29:254-261.
64. Haglund K., Leiner I., Kerksiek K., Buonocore L., Pamer E., Rose J.K. Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins. J. Virol. 2002, 76:7506-7517.
65. Haigwood N.L. Progress and challenges in therapies for AIDS in nonhuman primate models. J. Med. Primatol. 1999, 28:154-163.
66. Hammond S.A., Bollinger R.C., Stanhope P.E., Quinn T.C., Schwartz D., Clements M.L., Siliciano R.F. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines. J. Exp. Med. 1992, 176:1531-1542.
67. Hanke T., McMichael A. Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS. Immunol. Lett. 1999, 66:177-181.
68. Harouse J., Gettie A., Eshetu T., Fuller R., Blanchard J., Cheng-Mayer C. Co-transmission and growth of CCR5 and CxCR4 specific SHIVs after intravaginal or intravenous exposure. 19th Annual Symposium on Nonhuman Primate Models for AIDS 2001, November 7-10.
69. Heeney J., Akerblom L., Barnett S., Bogers W., Davis D., Fuller D., Koopman G., Lehner T., Mooij P., Morein B., de Giuli Morghen C., Rosenwirth B., Verschoor E., Wagner R., Wolf H. HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: complied preclinical efficacy data from trials with ten different HIV-1 vaccine candidates. Immunol. Lett. 1999, 66:189-195.
70. Hirsch V.M., Fuerst T.R., Sutter G., Carroll M.W., Yang L.C., Goldstein S., Piatak M.J., Elkins W.R., Alvord W.G., Montefiori D.C., Moss B., Lifson J.D. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J. Virol. 1996, 70:3741-3752.
71. Hladik F., Lentz G., Akridge R.E., Peterson G., Kelley H., McElroy A., McElrath M.J. Dendritic cell-T-cell interactions support coreceptor-independent human immunodeficiency virus type 1 transmission in the human genital tract. J. Virol. 1999, 73:5833-5842.
72. Hladik F., Lentz G., Delpit E., McElroy A., McElrath M.J. Coexpression of CCR5 and IL-2 in human genital but not blood T cells: implications for the ontogeny of the CCR5+ Th1 phenotype. J. Immunol. 1999, 163:2306-2313.
73. Hocini H., Bomsel M. Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins. J. Infect. Dis. 1999, 179(Suppl 3):S448-S453.
74. Hu J., Gardner M.B., Miller C.J. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J. Virol. 2000, 74:6087-6095.
75. Hu J., Pope M., Brown C., O'Doherty U., Miller C.J. Immunophenotypic characterization of SIV-infected dendritic cells in the cervix, vagina and draining lymph nodes of rhesus monkeys. Lab. Invest. 1998, 78:435-451.
76. Ibata B., Parr E.L., King N.J., Parr M.B. Migration of foreign lymphocytes from the mouse vagina into the cervicovaginal mucosa and to the iliac lymph nodes. Biol. Reprod. 1997, 56:537-543.
77. Imaoka K., Miller C.J., Kubota M., McChesney M.B., Lohman B., Yamamoto M., Fujihashi K., Someya K., Honda M., McGhee J.R., Kiyono H. Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissues. J. Immunol. 1998, 161(11):5952-5958.
78. Izmailova E., Bertley F.M., Huang Q., Makori N., Miller C.J., Young R.A., Aldovini A. HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages. Nat. Med. 2003, 9:191-197.
79. Jackson S., Prince S., Kulhavy R., Mestecky J. False positivity of enzyme-linked immunosorbent assay for measurement of secretory IgA antibodies directed at HIV type 1 antigens. AIDS Res. Hum. Retroviruses 2000, 16:595-602.
80. Jalanti R., Isliker H. Immunoglobulins in human cervicovaginal secretions. Int. Arch. Allergy Appl. Immunol. 1977, 53:402-408.
81. Jameson B., Baribaud F., Pohlmann S., Ghavimi D., Mortari F., Doms R.W., Iwasaki A. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J. Virol. 2002, 76:1866-1875.
82. Janoff E., Wahl S., Smith P. Antibodies to human immunodeficiency virus-1 (HIV) in the small intestine are primarily IgG, not IgA (abstract). Gastroenterology 1989, 96:236A.
83. Janoff E.N., Jackson S., Wahl S.M., Thomas K., Peterman J.H., Smith P.D. Intestinal mucosal immunoglobulins during human immunodeficiency virus type 1 infection. J. Infect. Dis. 1994, 170:299-307.
84. Jin X., Roberts C.G., Nixon D.F., Cao Y., Ho D.D., Walker B.D., Muldoon M., Korber B.T., Koup R.A. Longitudinal and cross-sectional analysis of cytotoxic T lymphocyte responses and their relationship to vertical human immunodeficiency virus transmission. ARIEL Project Investigators. J. Infect. Dis. 1998, 178:1317-1326.
85. Joag S.V., Li Z., Wang C., Foresman L., Jia F., Stephens E.B., Zhuge W., Narayan O. Passively administered neutralizing serum that protected macaques against infection with parenterally inoculated pathogenic simian-human immunodeficiency virus failed to protect against mucosally inoculated virus. AIDS Res. Hum. Retroviruses 1999, 15:391-394.
86. Joag S.V., Liu Z.Q., Stephens E.B., Smith M.S., Kumar A., Li Z., Wang C., Sheffer D., Jia F., Foresman L., Adany I., Lifson J., McClure H.M., Narayan O. Oral immunization of macaques with attenuated vaccine virus induces protection against vaginally transmitted AIDS. J. Virol. 1998, 72:9069-9078.
87. Johansson E.L., Rudin A., Wassen L., Holmgren J. Distribution of lymphocytes and adhesion molecules in human cervix and vagina. Immunology 1999, 96:272-277.
88. Johnson R.P. Mechanisms of protection against simian immunodeficiency virus infection. Vaccine 2002, 20:1985-1987.
89. Kabashima H., Yoneda M., Nagata K., Hirofuji T., Maeda K. The presence of chemokine (MCP-1, MIP-1alpha, MIP-1 beta, IP-10, RANTES)-positive cells and chemokine receptor (CCR5,CXCR3)-positive cells in inflamed human gingival tissues. Cytokine 2002, 20:70-77.
90. + lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J. Immunol. 2000, 164:1602-1611.
91. Kaul R., Trabattoni D., Bwayo J.J., Arienti D., Zagliani A., Mwangi F.M., Kariuki C., Ngugi E.N., MacDonald K.S., Ball T.B., Clerici M., Plummer F.A. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 1999, 13:23-29.
92. Kawamura T., Cohen S.S., Borris D.L., Aquilino E.A., Glushakova S., Margolis L.B., Orenstein J.M., Offord R.E., Neurath A.R., Blauvelt A. Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants. J. Exp. Med. 2000, 192:1491-1500.
93. Keefer M.C., Graham B.S., Belshe R.B., Schwartz D., Corey L., Bolognesi D.P., Stablein D.M., Montefiori D.C., McElrath M.J., Clements M.L. Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network. AIDS Res. Hum. Retroviruses 1994, 10:1713-1723.
94. Kell P.D., Barton S.E., Edmonds D.K., Boag F.C. HIV infection in a patient with Meyer-Rokitansky-Kuster-Hauser syndrome. J. R. Soc. Med. 1992, 85:706-707.
95. King B.F. The permeability of nonhuman primate vaginal epithelium: a freeze-fracture and tracer-perfusion study. J. Ultrastruct. Res. 1983, 83(1):99-110.
96. Korber B., Gaschen B., Yusim K., Thakallapally R., Kesmir C., Detours V. Evolutionary and immunological implications of contemporary HIV-1 variation. Br. Med. Bull. 2001, 58:19-42.
97. Koup R.A. Virus escape from CTL recognition. J. Exp. Med. 1994, 180:779-782.
98. Kozlowski P.A., Cu-Uvin S., Neutra M.R., Flanigan T.P. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect. Immun. 1997, 65:1387-1394.
99. Kozlowski P.A., Williams S.B., Lynch R.M., Flanigan T.P., Patterson R.R., Cu-Uvin S., Neutra M.R. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle. J. Immunol. 2002, 169:566-574.
100. Kubota M., Miller C.J., Imaoka K., Kawabata S., Fujihashi K., McGhee J.R., Kiyono H. Oral immunization with simian immunodeficiency virus p55 gag and cholera toxin elicits both mucosal IgA and systemic IgG immune responses in nonhuman primates. J. Immunol. 1997, 158:5321-5329.
101. Kunanusont C., Foy H.M., Kreiss J.K., Rerks-Ngarm S., Phanuphak P., Raktham S., Pau C.P., Young N.L. HIV-1 subtypes and male-to-female transmission in Thailand. Lancet 1995, 345:1078-1083.
102. Kutteh W.H., Prince S.J., Hammond K.R., Kutteh C.C., Mestecky J. Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation. Clin. Exp. Immunol. 1996, 104:538-542.
103. Kwong P.D., Doyle M.L., Casper D.J., Cicala C., Leavitt S.A., Majeed S., Steenbeke T.D., Venturi M., Chaiken I., Fung M., Katinger H., Parren P.W., Robinson J., Van Ryk D., Wang L., Burton D.R., Freire E., Wyatt R., Sodroski J., Hendrickson W.A., Arthos J. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 2002, 420:678-682.
104. Langhoff E., Terwilliger E.F., Bos H.J., Kalland K.H., Poznansky M.C., Bacon O.M., Haseltine W.A. Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures. Proc. Natl. Acad. Sci. USA 1991, 88:7998-8002.
105. Lee B., Sharron M., Montaner L.J., Weissman D., Doms R.W. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc. Natl. Acad. Sci. USA 1999, 96:5215-5220.
106. Leng Q., Borkow G., Weisman Z., Stein M., Kalinkovich A., Bentwich Z. Immune activation correlates better than HIV plasma viral load with CD4 T-cell decline during HIV infection. J. Acquir. Immune Defic. Syndr. 2001, 27:389-397.
107. Lifson J.D., Martin M.A. One step forwards, one step back. Nature 2002, 415:272-273.
108. Liu R., Paxton W.A., Choe S., Ceradini D., Martin S.R., Horuk R., MacDonald M.E., Stuhlmann H., Koup R.A., Landau N.R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996, 86:367-377.
109. Lohman B.L., Miller C.J., McChesney M.B. Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. J. Immunol. 1995, 155:5855-5860.
110. Lü F.X., Abel K., Ma Z., Rourke T., Lu D., Torten J., McChesney M., Miller C.J. The strength of B cell immunity in female rhesus macaques is controlled by CD8+ T cells under the influence of ovarian steroid hormones. Clin. Exp. Immunol. 2002, 128:10-20.
111. Lü F.X., Ma Z., Rourke T., Srinivasan S., McChesney M., Miller C.J. Immunoglobulin concentrations and antigenspecific antibody levels in cervicovaginal lavages of rhesus macaques are influenced by the stage of the menstrual cycle. Infect. Immun. 1999, 67:6321-6328.
112. Lu N.S., Belec L., Martin P.M., Pillot J. Enhanced local immunity in vaginal secretions of HIV-infected women. Lancet 1991, 338:323-324.
113. Lu X.S., Belec L., Pillot J. Anti-gp 160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women. J. Infect. Dis. 1993, 167:1189-1192.
114. Ma Z., Lu F.X., Torten M., Miller C.J. The number and distribution of immune cells in the cervicovaginal mucosa remain constant throughout the menstrual cycle of rhesus macaques. Clin. Immunol. 2001, 100:240-249.
115. MacDougall T.H., Shattock R.J., Madsen C., Chain B.M., Katz D.R. Regulation of primary HIV-1 isolate replication in dendritic cells. Clin. Exp. Immunol. 2002, 127:66-71.
116. Mandelbrot L., Burgard M., Teglas J.P., Benifla J.L., Khan C., Blot P., Vilmer E., Matheron S., Firtion G., Blanche S., Mayaux M.J., Rouzioux C. Frequent detection of HIV-1 in the gastric aspirates of neonates born to HIV-infected mothers. AIDS 1999, 13:2143-2149.
117. Marthas M., Sutjipto S., Miller C., Higgins J., Torten J., Unger R., Kiyono H., McGhee J., Marx P., Pedersen N. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against intravenous and intravaginal challenge. Vaccines 1992 1992, 117-122. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. F. Brown, R.M. Chanock, H.S. Ginsberg, R.A. Lerner (Eds.).
118. Marx P.A., Spira A.I., Gettie A., Dailey P.J., Veazey R.S., Lackner A.A., Mahoney C.J., Miller C.J., Claypool L.E., Ho D.D., Alexander N.J. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat. Med. 1996, 2:1084-1089.
119. Mascola J.R., Stiegler G., VanCott T.C., Katinger H., Carpenter C.B., Hanson C.E., Beary H., Hayes D., Frankel S.S., Birx D.L., Lewis M.G. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 2000, 6(2):207-210.
120. Masurier C., Salomon B., Guettari N., Pioche C., Lachapelle F., Guigon M., Klatzmann D. Dendritic cells route human immunodeficiency virus to lymph nodes after vaginal or intravenous administration to mice. J. Virol. 1998, 72(10):7822-7829.
121. Mathewson J.J., Jiang Z.D., DuPont H.L., Chintu C., Luo N., Zumla A. Intestinal secretory IgA immune response against human immunodeficiency virus among infected patients with acute and chronic diarrhea. J. Infect. Dis. 1994, 169:614-617.
122. Mazanec M.B., Nedrud J.G., Kaetzel C.S., Lamm M.E. A three-tiered view of the role of IgA in mucosal defense. Immunol. Today 1993, 14:430-435.
123. Mazzoli S., Trabattoni D., Lo Caputo S., Piconi S., Ble C., Meacci F., Ruzzante S., Salvi A., Semplici F., Longhi R., Fusi M.L., Tofani N., Biasin M., Villa M.L., Mazzotta F., Clerici M. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat. Med. 1997, 3:1250-1257.
124. McChesney M., Sawaii E., Miller C.J. Simian immunodeficiency virus. Persistent Viral Infections 1999, 321-346. John Wiley and Sons, West Sussex, England. R. Ahmed, I. Chen (Eds.).
125. + T-cell-proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV. J. Virol. 1998, 72:10029-10035.
126. McElrath M.J., Corey L., Montefiori D., Wolff M., Schwartz D., Keefer M., Belshe R., Graham B.S., Matthews T., Wright P., Gorse G., Dolin R., Berman P., Francis D., Duliege A.M., Bolognesi D., Stablein D., Ketter N., Fast P. A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation Group. AIDS Res. Hum. Retroviruses 2000, 16:907-919.
127. McElrath M.J., Siliciano R.F., Weinhold K.J. HIV type 1 vaccine-induced cytotoxic T cell responses in phase I clinical trials: detection, characterization, and quantitation. AIDS Res. Hum. Retroviruses 1997, 13:211-216.
128. McMichael A.J., Hanke T. Is an HIV vaccine possible?. Nat. Med. 1999, 5:612-614.
129. Mellors J.W., Kingsley L.A., Rinaldo C.R., Todd J.A., Hoo B.S., Kokka R.P., Gupta P. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 1995, 122:573-579.
130. Mellors J.W., Rinaldo C.R., Gupta P., White R.M., Todd J.A., Kingsley L.A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996, 272:1167-1170.
131. Meng G., Wei X., Wu X., Sellers M.T., Decker J.M., Moldoveanu Z., Orenstein J.M., Graham M.F., Kappes J.C., Mestecky J., Shaw G.M., Smith P.D. Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells. Nat. Med. 2002, 8:150-156.
132. Miller C.J., Alexander N.J., Sutjipto S., Lackner A.A., Gettie A., Hendrickx A.G., Lowenstine L.J., Jennings M., Marx P.A. Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus. J. Virol. 1989, 63:4277-4284.
133. Miller C.J., Alexander N.J., Vogel P., Anderson J., Marx P.A. Mechanism of genital transmission of SIV: a hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques. J. Med. Primatol. 1992, 21:64-68.
134. Miller C.J., Marthas M., Greenier J., Lu D., Dailey P.J., Lu Y. In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques. J. Virol. 1998, 72:3248-3258.
135. Miller C.J., Marthas M., Torten J., Alexander N.J., Moore J.P., Doncel G.F., Hendrickx A.G. Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J. Virol. 1994, 68:6391-6400.
136. Miller C.J., McChesney M., Moore P.F. Langerhans' cells, macrophages and lymphocyte subsets in the cervix and vagina of rhesus macaques. Lab. Invest. 1992, 67:628-634.
137. Miller C.J., McChesney M.B., Lu X.S. Mucosal immune responses to SIV infection. Semin. Virol. 1996, 7:139-145.
138. Miller C.J., McChesney M.B., Lü X., Dailey P.J., Chutkowski C., Lu D., Brosio P., Roberts B., Lu Y. Rhesus macaques previously infected with SHIV are protected from vaginal challenge with pathogenic SIVmac239. J. Virol. 1997, 71:1911-1921.
139. Miller C.J., McGhee J.R., Gardner M.B. Mucosal Immunity, HIV transmission and AIDS. Lab. Invest. 1993, 68:129-145.
140. Mitchell E.A., Bergmeier L.A., Doyle C., Brookes R., Hussain L.A., Wang Y., Lehner T. Homing of mononuclear cells from iliac lymph nodes to the genital and rectal mucosa in non-human primates. Eur. J. Immunol. 1998, 28(10):3066-3074.
141. Moja P., Tranchat C., Tchou I., Pozzetto B., Lucht F., Desgranges C., Genin C. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients. J. Infect. Dis. 2000, 181:1607-1613.
142. Moriyama A., Shimoya K., Ogata I., Kimura T., Nakamura T., Wada H., Ohashi K., Azuma C., Saji F., Murata Y. Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle. Mol. Hum. Reprod. 1999, 5:656-661.
143. Morris H.H., Gatter K.C., Stein H., Mason D.Y. Langerhans' cells in human cervical epithelium: an immunohistologic, immunohistological study. Br. J. Obstet. Gynaecol. 1983, 90:400-411.
144. Murphey-Corb M., Wilson L.A., Trichel A.M., Roberts D.E., Xu K., Ohkawa S., Woodson B., Bohm R., Blanchard J. Selective induction of protective MHC class I-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa. J. Immunol. 1999, 162:540-549.
145. Musey L., Ding Y., Elizaga M., Ha R., Celum C., Mc Elrath M.J. HIV-1 vaccination administered intramuscularly can induce both systemic and mucosal T-cell immunity in HIV-1 infected individuals. J. Immunol. 2003, 171:1094-1101.
146. Musey L., Ding Y., Cao J., Lee J., Galloway C., Yuen A., Jerome K.R., McElrath M.J. Ontogeny and specificities of mucosal and blood human immunodeficiency virus type 1-specific CD8(+) cytotoxic T lymphocytes. J. Virol. 2003, 77:291-300.
147. Musey L., Hu Y., Eckert L., Christensen M., Karchmer T., McElrath M.J. HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women. J. Exp. Med. 1997, 185:293-303.
148. Musey L., Hughes J., Schacker T., Shea T., Corey L., McElrath M.J. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N. Engl. J. Med. 1997, 337:1267-1274.
149. Nilsson C., Makitalo B., Thorstensson R., Norley S., Binninger-Schinzel D., Cranage M., Rud E., Biberfeld G., Putkonen P. Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm. AIDS 1998, 12(17):2261-2270.
150. Novell M.K., Benrudi G.I., Thompson R.J. Investigation of microtrauma after sexual intercourse. J. Repord. Med. 1984, 29:269-271.
151. Nuovo G.J., Forde A., MacConnell P., Fahrenwald R. In situ detection of PCR-amplified HIV-1 nucleic acids and tumor necrosis factor cDNA in cervical tissues. Am. J. Pathol. 1993, 143:40-48.
152. Paavonen T., Andersson L.C., Adlercreutz H. Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures. J. Exp. Med. 1981, 154(6):1935-1945.
153. Parren P.W., Marx P.A., Hessell A.J., Luckay A., Harouse J., Cheng-Mayer C., Moore J.P., Burton D.R. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. J. Virol. 2001, 75:8340-8347.
154. Patterson B.K., Czerniewski M., Andersson J., Sullivan Y., Su F., Jiyamapa D., Burki Z., Landay A. Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes. Clin. Immunol. 1999, 91:254-262.
155. Patterson S., Knight S.C. Susceptibility of human peripheral blood dendritic cells to infection by human immunodeficiency virus. J. Gen. Virol. 1987, 68:1177-1181.
156. Patton D.L., Thwin S.S., Meier A., Hooton T.M., Stapleton A.E., Eschenbach D.A. Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle. Am. J. Obstet. Gynecol. 2000, 183:967-973.
157. Phillips D.M., Bourinbaiar A.S. Mechanism of HIV spread from lymphocytes to epithelia. Virology 1992, 186:261-273.
158. Pohlmann S., Baribaud F., Doms R.W. DC-SIGN and DC-SIGNR: helping hands for HIV. Trends Immunol. 2001, 22:643-646.
159. Pomerantz R.J., de la Monte S.M., Donegan S.P., Rota T.R., Vogt M.W., Craven D.E., Hirsch M.S. Human immunodeficiency virus (HIV) infection of the uterine cervix. Ann. Intern. Med. 1988, 108:321-327.
160. Prakash M., Kapembwa M.S., Gotch F., Patterson S. Oral contraceptive use induces upregulation of the CCR5 chemokine receptor on CD4(+) T cells in the cervical epithelium of healthy women. J. Reprod. Immunol. 2002, 54:117-131.
161. Quayle A.J., Coston W.M., Trocha A.K., Kalams S.A., Mayer K.H., Anderson D.J. Detection of HIV-1-specific CTLs in the semen of HIV-infected individuals. J. Immunol. 1998, 161:4406-4410.
162. Quesnel A., Cu-Uvin S., Murphy D., Ashley R.L., Flanigan T., Neutra M.R. Comparative analysis of methods for collection and measurement of immunoglobulins in cervical and vaginal secretions of women. J. Immunol. Methods 1997, 202:153-161.
163. Quinn T.C., Wawer M.J., Sewankambo N., Serwadda D., Li C., Wabwire-Mangen F., Meehan M.O., Lutalo T., Gray R.H. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N. Engl. J. Med. 2000, 342:921-929.
164. Raux M., Finkielsztejn L., Salmon-Ceron D., Bouchez H., Excler J.L., Dulioust E., Grouin J.M., Sicard D., Blondeau C. Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects. AIDS Res. Hum. Retroviruses 1999, 15:1365-1376.
165. Reece J.C., Handley A.J., Anstee E.J., Morrison W.A., Crowe S.M., Cameron P.U. HIV-1 selection by epidermal dendritic cells during transmission across human skin. J. Exp. Med. 1998, 187:1623-1631.
166. Reinhart T.A., Fallert B.A., Pfeifer M.E., Sanghavi S., Capuano S., Rajakumar P., Murphey-Corb M., Day R., Fuller C.L., Schaefer T.M. Increased expression of the inflammatory chemokine CXC chemokine ligand 9/monokine induced by interferon-gamma in lymphoid tissues of rhesus macaques during simian immunodeficiency virus infection and acquired immunodeficiency syndrome. Blood 2002, 99:3119-3128.
167. Robboy S.J., Prade M., Cunha G. Vagina. Histology for Pathologists 1992, 881-892. Raven Press, North Holland, NY. S.S. Sternberg (Ed.).
168. Roncalli M., Sideri M., Gie P., Servida E. Immunophenotypic analysis of the transformation zone of human cervix. Lab. Invest. 1988, 58:141-149.
169. Rottman J.B., Ganley K.P., Williams K., Wu L., Mackay C.R., Ringler D.J. Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am. J. Pathol. 1997, 151:1341-1351.
170. Rubbert A., Combadiere C., Ostrowski M., Arthos J., Dybul M., Machado E., Cohn M.A., Hoxie J.A., Murphy P.M., Fauci A.S., Weissman D. Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry. J. Immunol. 1998, 160:3933-3941.
171. Salmon-Ceron D., Excler J.L., Finkielsztejn L., Autran B., Gluckman J.C., Sicard D., Matthews T.J., Meignier B., Valentin C., El Habib R., Blondeau C., Raux M., Moog C., Tartaglia J., Chong P., Klein M., Milcamps B., Heshmati F., Plotkin S. Safety and immunogenicity of a live recombinant canarypox virus expressing HIV type 1 gp120 MN MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV infection. AGIS Group and L'Agence Nationale de Recherches sur Le Sida. AIDS Res. Hum. Retroviruses 1999, 15:633-645.
172. Schmitz J.E., Veazey R.S., Kuroda M.J., Levy D.B., Seth A., Mansfield K.G., Nickerson C.E., Lifton M.A., Alvarez X., Lackner A.A., Letvin N.L. Simian immunodeficiency virus (SIV)-specific cytotoxic T lymphocytes in gastrointestinal tissues of chronically SIV-infected rhesus monkeys. Blood 2001, 98:3757-3761.
173. Schneider T., Zippel T., Schmidt W., Pauli G., Heise W., Wahnschaffe U., Riecken E.O., Zeitz M., Ullrich R. Abnormal predominance of IgG in HIV-specific antibodies produced by short-term cultured duodenal biopsy specimens from HIV-infected patients. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1997, 16:333-339.
174. Schneider T., Zippel T., Schmidt W., Pauli G., Wahnschaffe U., Chakravarti S., Heise W., Riecken E.O., Zeitz M., Ullrich R. Increased immunoglobulin G production by short term cultured duodenal biopsy samples from HIV infected patients. Gut 1998, 42:357-361.
175. Schumacher G.F.B., Yang S.L. Cyclic changes of immunoglobulins and specific antibodies in human and rhesus monkey cervical mucus. The Uterine Cervix in Reproduction 1977, 187-203. Georg Thieme Verlag, Stuttgart. V. Insler, G. Bettendorf (Eds.).
176. Sewankambo N., Gray R.H., Wawer M.J., Paxton L., McNaim D., Wabwire-Mangen F., Serwadda D., Li C., Kiwanuka N., Hillier S.L., Rabe L., Gaydos C.A., Quinn T.C., Konde-Lule J. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997, 350:546-550.
177. Shacklett B.L., Beadle T.J., Pacheco P.A., Grendell J.H., Haslett P.A., King A.S., Ogg G.S., Basuk P.M., Nixon D.F. Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjects. Virology 2000, 270:317-327.
178. Shacklett B.L., Cu-Uvin S., Beadle T.J., Pace C.A., Fast N.M., Donahue S.M., Caliendo A.M., Flanigan T.P., Carpenter C.C., Nixon D.F. Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface. AIDS 2000, 14:1911-1915.
179. Shattock R.J., Griffin G.E., Gorodeski G.I. In vitro models of mucosal HIV transmission. Nat. Med. 2000, 6:607-608.
180. Shiver J.W., Fu T.M., Chen L., Casimiro D.R., Davies M.E., Evans R.K., Zhang Z.Q., Simon A.J., Trigona W.L., Dubey S.A., Huang L., Harris V.A., Long R.S., Liang X., Handt L., Schleif W.A., Zhu L., Freed D.C., Persaud N.V., Guan L., Punt K.S., Tang A., Chen M., Wilson K.A., Collins K.B., Heidecker G.J., Fernandez V.R., Perry H.C., Joyce J.G., Grimm K.M., Cook J.C., Keller P.M., Kresock D.S., Mach H., Troutman R.D., Isopi L.A., Williams D.M., Xu Z., Bohannon K.E., Volkin D.B., Montefiori D.C., Miura A., Krivulka G.R., Lifton M.A., Kuroda M.J., Schmitz J.E., Letvin N.L., Caulfield M.J., Bett A.J., Youil R., Kaslow D.C., Emini E.A. Replication-incompetent adenoviral vaccine vector elicits effective antiimmunodeficiency-virus immunity. Nature 2002, 415:331-335.
181. Skott P., Lucht E., Julander I., Dillner J., Bjorling E. Salivary sIgA response in HIV-1 infection. J. Acquir. Immune Defic. Syndr. 1999, 21:73-80.
182. Skurnick J.H., Palumbo P., DeVico A., Shacklett B.L., Valentine F.T., Merges M., Kamin-Lewis R., Mestecky J., Denny T., Lewis G.K., Lloyd J., Praschunus R., Baker A., Nixon D.F., Stranford S., Gallo R., Vermund S.H., Louria D.B. Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure. J. Infect. Dis. 2002, 185:428-438.
183. Smith S.M., Baskin G.B., Marx P.A. Estrogen protects against vaginal transmission of simian immunodeficiency virus. J. Infect. Dis. 2000, 182(3):708-715.
184. Sodora D.L., Gettie A., Miller C.J., Marx P.A. Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Res. Hum. Retroviruses 1998, 14(Suppl 1):S119-S123.
185. Spira A.I., Marx P.A., Patterson B.K., Mahoney J., Koup R.A., Wolinsky S.M., Ho D.D. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med. 1996, 183:215-225.
186. Stahl-Hennig C., Steinman R.M., Tenner-Racz K., Pope M., Stolte N., Matz-Rensing K., Grobschupff G., Raschdorff B., Hunsmann G., Racz P. Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus. Science 1999, 285:1261-1265.
187. Stevceva L., Kelsall B., Nacsa J., Moniuszko M., Hel Z., Tryniszewska E., Franchini G. Cervicovaginal lamina propria lymphocytes: phenotypic characterization and their importance in cytotoxic T-lymphocyte responses to simian immunodeficiency virus SIVmac251. J. Virol. 2002, 76:9-18.
188. Stewart G.J., Tyler J.P., Cunningham A.L., Barr J.A., Driscoll G.L., Gold J., Lamont B.J. Transmission of human T-cell lymphotropic virus type III (HTLV-III) by artificial insemination by donor. Lancet 1985, 2:581-585.
189. Sthoeger Z.M., Chiorazzi N., Lahita R.G. Regulation of the immune response by sex hormones. I. In vitro effects of estradiol and testosterone on pokeweed mitogen-induced human B cell differentiation. J. Immunol. 1988, 141:91-98.
190. Strathdee S.A., Hogg R.S., O'Shaughnessy M.V., Montaner J.S., Schechter M.T. A decade of research on the natural history of HIV infection: Part 2. Cofactors. Clin. Invest. Med. 1996, 19:121-130.
191. Sturm-Ramirez K., Gaye-Diallo A., Eisen G., Mboup S., Kanki P.J. High levels of tumor necrosis factor-alpha and interleukin-1 beta in bacterial vaginosis may increase susceptibility to human immunodeficiency virus. J. Infect. Dis. 2000, 182:467-473.
192. Syrbe U., Siveke J., Hamann A. Th1/Th2 subsets: distinct differences in homing and chemokine receptor expression?. Springer Semin. Immunopathol. 1999, 21:263-285.
193. Turville S.G., Arthos J., Donald K.M., Lynch G., Naif H., Clark G., Hart D., Cunningham A.L. HIV gp120 receptors on human dendritic cells. Blood 2001, 98:2482-2488.
194. Van Rompay K.K., Berardi C.J., Dillard-Telm S., Tarara R.P., Canfield D.R., Valverde C.R., Montefiori D.C., Cole K.S., Montelaro R.C., Miller C.J., Marthas M.L. Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection. J. Infect. Dis. 1998, 177:1247-1259.
195. Veazey R.S., Shattock R.J., Pope M., Kirijan J.C., Jones J., Hu Q., Ketas T., Marx P.A., Klasse P.J., Burton D.R., Moore J.P. Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat. Med. 2003, 9:343-346.
196. Wallace J.I., Porter J., Weiner A., Steinberg A. Oral sex, crack smoking, and HIV infection among female sex workers who do not inject drugs. Am. J. Public Health 1997, 87:470.
197. Weissman D., Rubbert A., Combadiere C., Murphy P.M., Fauci A.S. Dendritic cells express and use multiple HIV coreceptors. Adv. Exp. Med. Biol. 1997, 417:401-406.
198. Williams S.B., Flanigan T.P., Cu-Uvin S., Mayer K., Williams P., Ettore C.A., Artenstein A.W., Duerr A., VanCott T.C. Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1. Clin. Infect. Dis. 2002, 35:611-617.
199. Wortley P.M., Hammett T.A., Fleming P.L. Donor insemination and human immunodeficiency virus transmission. Obstet. Gynecol. 1998, 91:515-518.
200. Wright P.F., Kozlowski P.A., Rybczyk G.K., Goepfert P., Staats H.F., VanCott T.C., Trabattoni D., Sannella E., Mestecky J. Detection of mucosal antibodies in HIV type 1-infected individuals. AIDS Res. Hum. Retroviruses 2002, 18:1291-1300.
201. Wu L., Bashirova A.A., Martin T.D., Villamide L., Mehlhop E., Chertov A.O., Unutmaz D., Pope M., Carrington M., KewalRamani V.N. Rhesus macaque dendritic cells efficiently transmit primate lentiviruses independently of DC-SIGN. Proc. Natl. Acad. Sci. USA 2002, 99:1568-1573.
202. Yoshino N., Ami Y., Someya K., Ando S., Shinohara K., Tashiro F., Lu Y., Honda M. Protective immune responses induced by a non-pathogenic simian/human immunodeficiency virus (SHIV) against a challenge of a pathogenic SHIV in monkeys. Microbiol. Immunol. 2000, 44:363-372.
203. Zacharopoulos V.R., Perotti M.E., Phillips D.M. A role for cell migration in the sexual transmission of HIV-1?. Curr. Biol. 1997, 7:534-537.
204. Zaitseva M., Blauvelt A., Lee S., Lapham C.K., Klaus-Kovtun V., Mostowski H., Manischewitz J., Golding H. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nat. Med. 1997, 3:1369-1375.
205. Zhang L., He T., Talal A., Wang G., Frankel S.S., Ho D.D. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5. J. Virol. 1998, 72:5035-5045.
206. Zhang Z.Q., Fu T.M., Casimiro D.R., Davies M.E., Liang X., Schleif W.A., Handt L., Tussey L., Chen M., Tang A., Wilson K.A., Trigona W.L., Freed D.C., Tan C.Y., Horton M., Emini E.A., Shiver J.W. Mamu-A*01 allele-mediated attenuation of disease progression in simian-human immunodeficiency virus infection. J. Virol. 2002, 76:12845-12854.
207. Zhu T., Corey L., Hwangbo Y., Lee J., Learn G.H., Mullins J.I., McElrath M.J. Persistence of extraordinarily low levels of genetically homogenous HW-1 in exposed seronegative individuals. J. Virol. 2003, 77:6108-6116.
208. Zoeteweij J.P., Blauvelt A. HIV-dendritic cell interactions promote efficient viral infection of T cells. J. Biomed. Sci. 1998, 5:253-259.